2008 Brochure


Download the Central Labs Conference Brochure

Customer Service

Have a question about this event?
Customer Service representatives are available to help from 8 AM - 6 PM EST
Call 888-670-8200


Need Technical Assistance With this Website?
Send an email to IIR's Web Department

Biomarker Development

Biomarker Development

Special sessions just for Biomarker Development related content
B2 Getting the Most Technical Expertise from Your Labs: Biomarkers, Personalized Medicine, Diagnostics, and Assay Development
8:00Registration and Morning Coffee hosted by
9:00Workshop Begins
9:00Personalized Medicine and Its Impact on Drug development and Commercialization
David Lester, Senior Vice President, Strategy and Corporate Development, GENE EXPRESS
Case Study
9:30 Companion Diagnostics: Implementation models for Rx/Dx Co development Concept
David Johnston, PhD, Vice President, Companion Diagnostics, LABCORP; Chief Scientific Officer, ESOTERIX CLINICAL TRIALS SERVICES
10:00Biomarkers in Oncology
10:30Morning Networking Break
Case Study
11:00 Biomarkers as Potential Companion Diagnostics: A New Paradigm for Central Laboratories Services
Maribeth Raines, PhD, Director, Scientific Affairs, QUEST DIAGNOSTICS CLLINICAL TRIALS
11:30Archival Surgical Pathology Specimens: A New Exercise in Clinical Trials
Carol W Johnson, DVM, PhD, DACVP, Pathology Director, AMGEN - Invited
Joseph Schappert, MD, Global Medical Director, ICON CENTRAL LABORATORIES
12:00OPEN SESSION
12:30Networking Luncheon
1:45The Use of Imaging Biomarkers in Phase I/II trials
Haren Rupani, Global Head, Oncology Clinical Imaging, NOVARTIS PHARMACEUTICALS CORPORATION
2:15Using Technical Consulting Services to Avoid Pitfalls in Biomarker Data Collection
Rajani Prasad, PhD, Vice President, Clinical Research, CRL CLINICAL REFERENCNE LABORATORY GLOBAL SERVICES
3:15Afternoon Networking Break
2:45Using Robust QT in Drug Development for Earlier Evaluation and Compound Advancement
William Wheeler, MD, FACC, Global Medical Director, Centralized Cardiac Services, MDS PHARMA SERVICES
3:45Kidney Injury Molecule-1: Biology and Analytical Validation
Shalini Chaturvedi, Senior Scientist, Biomarker Services, COVANCE CENTRAL LABORATORY SERVICES
Panel Discussion
4:30

Technical Hot Topics

Panelists:
Haren Rupani, Global Head, Oncology Clinical Imaging, NOVARTIS PHARMACEUTICALS CORPORATION
David Lester, Senior Vice President, Strategy and Corporate Development, GENE EXPRESS
David Johnston, PhD, Vice President, Companion Diagnostics, LABCORP; Chief Scientific Officer, ESOTERIX CLINICAL TRIALS SERVICES

Ralph McDade, RULES BASED MEDICINE

5:15-6:45Networking Reception
Networking, Networking and More Networking!
Please join us for the Partnering with Central Labs Welcome
Reception Monday, January 26th, 5:15-6:45
Mingle with your colleagues and clients and have a drink on us! Join us
as we welcome everyone and kick off our 7th Annual Conference.
Track C: Improving and Standardizing ECG and Cardiac Safety Studies
1:35

Working Together to Develop Biomarkers for Safety Monitoring and Surrogate Endpoints

Samir Khleif, Head, Cancer Vaccine Section Investigator, NATIONAL CANCER INSTITUTE, NIH
Wendy R. Sanhai, PhD, Senior Scientific Advisor, Office of the Commissioner, FDA

William Wheeler, MD, Chief Scientific Officer, MDS PHARMA SERVICES
Dr. Patrice Hugo Vice-President of Scientific Affairs, MDS PHARMA SERVICES

             
BROCHURE REGISTER  GET UPDATES  RECOMMEND CONTACT HOME    BACK TO TOP
©2008 IIR HOLDINGS, LTD. All Rights Reserved.